Biocon plans to introduce generic versions of the weight-loss drug Wegovy in India and Canada by 2027, according to CEO Siddharth Mittal.

Hengrui Pharma and Kailera Therapeutics have reported positive topline data from the former’s Phase III trial (HRS9531-301) ...

Weight loss jabs such as Wegovy and Mounjaro may offer a protective effect against dementia and stroke, according to a new study.

A major ICMR-led study reveals that 1 in 4 Indian married couples are overweight or obese, with urban, affluent, and media-exposed households showing the highest spousal weight concordance., Health, T ...

Since the onset of the COVID-19 pandemic, the prevalence of obesity in Canada has increased at a greater rate.

Reducing calories from ultra-processed foods, improving access to whole foods, and better understanding how these products ...

Research from ENDO 2025 reveals that GLP-1 anti-obesity medications not only aid in weight loss but also improve testosterone ...

Experts have noted a concerning and mysterious rise in rates of bowel cancer among young adults, defined in cancer terms as ...

The game-changing weight loss jabs have ushered in a new era in the war on obesity, but have also been linked to other health ...

From samosas to pizzas, your favourite snacks might be comforting, but they could also be harming your health. A known ...

Preclinical study shows oral PL7737 agonist outperforms tirzepatide alone in rodent models, supporting Palatin’s plans for ...

Shipra Patel, global therapeutic area section head, endocrinology, global head, pediatrics, Parexel, explains how a focused GLP-1 task force and deep market insights are helping sponsors stand out in ...